rewirebio.iobenchmarks
← Back to the use case
Source

Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

13059_2020_1954_MOESM9_ESM.xlsx · Peer-reviewed

DOI: 10.1186/s13059-020-01954-z

What this source contributed

Records in this release that cite this source. A record can cite several sources.

Results

Values as the source printed them. Compare results only under compatible protocols, datasets and metrics.

Model or configurationMetricValueDatasetEvaluation
CADD (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CADD (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CADD on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CanDrA (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CanDrA on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.65 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.65 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.65 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.65 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CHASM (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.64 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CHASM on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.63 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.63 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.63 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.63 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-cancer (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.63 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-population (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-population on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-population (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-population on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-population (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-population on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-population (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-population on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
CTAT-population (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)CTAT-population on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
DANN (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)DANN on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
DANN (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)DANN on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
DANN (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)DANN on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
DANN (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)DANN on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
DANN (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.59 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)DANN on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
DEOGEN2 (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)DEOGEN2 on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
DEOGEN2 (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)DEOGEN2 on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
DEOGEN2 (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)DEOGEN2 on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
DEOGEN2 (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)DEOGEN2 on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
DEOGEN2 (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)DEOGEN2 on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Eigen (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)Eigen on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Eigen (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)Eigen on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Eigen (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)Eigen on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Eigen (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)Eigen on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Eigen (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)Eigen on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Eigen-PC (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)Eigen-PC on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Eigen-PC (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)Eigen-PC on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Eigen-PC (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)Eigen-PC on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Eigen-PC (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)Eigen-PC on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
Eigen-PC (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.66 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)Eigen-PC on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
FATHMM-cancer (Chen et al. 2020)Accuracy (OncoKB benchmark (positive set not stated), median-score threshold)0.67 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)FATHMM-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
FATHMM-cancer (Chen et al. 2020)Negative predictive value (OncoKB benchmark (positive set not stated), median-score threshold)0.67 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)FATHMM-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
FATHMM-cancer (Chen et al. 2020)Precision (OncoKB benchmark (positive set not stated), median-score threshold)0.67 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)FATHMM-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
FATHMM-cancer (Chen et al. 2020)Recall (OncoKB benchmark (positive set not stated), median-score threshold)0.67 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)FATHMM-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)
FATHMM-cancer (Chen et al. 2020)Specificity (OncoKB benchmark (positive set not stated), median-score threshold)0.67 fractionOncoKB-annotated somatic missense mutations (oncogenic, likely oncogenic and likely neutral)FATHMM-cancer on OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020)

Claims

Statements this source supports, each with where in the source it was checked.

  • Evidence summary: somatic small-variant oncogenicity: Summary Two predictor comparisons join the existing OncoVI evidence; their values cannot be pooled. In Chen et al. 2020 (peer reviewed), 33 predictors scored somatic missense mutations labelled by OncoKB curation or by the authors' own cell viability assays, with likely neutral or assay-neutral somatic negatives. The authors co-developed one scored tool, CanDrA, and developed none of the others. With each tool's own default calls, the highest accuracy was 0.70 on OncoKB labels (DEOGEN2, sensitivity 0.87, specificity 0.51), and several tools called most neutral mutations damaging, for example M-CAP with sensitivity 0.97 and specificity 0.11, and CanDrA with specificity 0.17 and the lowest accuracy, 0.49. On the assay labels the highest default accuracy was 0.65 (PrimateAI). When each tool's median score on the test draw was used as the threshold, which ranks tools but is not an operating point a reviewer could apply, the highest accuracy was 0.69 on OncoKB labels (PROVEAN and VEST4) and 0.70 on assay labels (CTAT-cancer and PrimateAI), and FATHMM-disease scored 0.50 on OncoKB labels. Chen et al. print each value as a mean with a range of two standard deviations over 100 draws, not a confidence interval, and do not say which OncoKB positive set fed these tables. In a single-author bioRxiv preprint that is not peer reviewed (Lee 2026), 49 scores were compared on Cancer Gene Census missense variants whose negatives are germline-benign labels (ClinVar benign or likely benign, and gnomAD common variants), which this use case does not accept as somatic controls. In that table 42 of the 49 scores had a lower AUROC on oncogene variants than on tumour-suppressor variants, for example AlphaMissense 0.885 against 0.900 and CADD 0.821 against 0.894, while popEVE went the other way (0.900 against 0.842). The highest all-gene AUROC was 0.876 (MutScore); these AUROC values are rounded here to three decimals from the table's full precision. None of these comparisons covers small indels, calibrated probabilities, criterion-level evidence strength, drug response or reviewer agreement. (somatic-oncogenicity-20261009-source-chen2020-additional-file-9 and -10: Benchmark 2; somatic-oncogenicity-20261009-source-chen2020-additional-file-21 and -22: Benchmark 5; somatic-oncogenicity-20261009-source-chen2020: Methods and reference 7; somatic-oncogenicity-20261009-source-lee2026-oncocal-tool-performance: tables/tool_performance.tsv; somatic-oncogenicity-20261009-source-lee2026: Methods and Results)
  • Relevance of OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020) to "Assess somatic small-variant oncogenicity": Assessed by OncoKB benchmark (positive set not stated), median-score threshold (Chen et al. 2020 Additional file 9) (somatic-oncogenicity-20261009-source-chen2020-additional-file-9: Additional file 9; somatic-oncogenicity-20261009-source-chen2020: Results 'Benchmark 2'; Methods)

Models, benchmarks and other records

Protocols (1)

Evaluations (33)

Use cases (1)

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

17 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-02-a7f03c9e55a5
Property and statementOriginal source and locationReview and provenance
Artifact SHA-256
64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c
Source metadata		Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

Original source ↗

No field-specific location recorded

Version: 13059_2020_1954_MOESM9_ESM.xlsx
Retrieved: 2026-10-09T20:46:04Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_sha256

Source artifact SHA-256: 64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Artifact url
https://static-content.springer.com/esm/art%3A10.1186%2Fs13059-020-01954-z/MediaObjects/13059_2020_1954_MOESM9_ESM.xlsx
Source metadata		Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

Original source ↗

No field-specific location recorded

Version: 13059_2020_1954_MOESM9_ESM.xlsx
Retrieved: 2026-10-09T20:46:04Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.artifact_url

Source artifact SHA-256: 64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Doi
10.1186/s13059-020-01954-z
Source metadata		Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

Original source ↗

No field-specific location recorded

Version: 13059_2020_1954_MOESM9_ESM.xlsx
Retrieved: 2026-10-09T20:46:04Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.doi

Source artifact SHA-256: 64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Licence
CC-BY-4.0
Source metadata		Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

Original source ↗

No field-specific location recorded

Version: 13059_2020_1954_MOESM9_ESM.xlsx
Retrieved: 2026-10-09T20:46:04Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.licence

Source artifact SHA-256: 64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Media type
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Source metadata		Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

Original source ↗

No field-specific location recorded

Version: 13059_2020_1954_MOESM9_ESM.xlsx
Retrieved: 2026-10-09T20:46:04Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.media_type

Source artifact SHA-256: 64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Publication status
peer_reviewed
Source metadata		Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

Original source ↗

No field-specific location recorded

Version: 13059_2020_1954_MOESM9_ESM.xlsx
Retrieved: 2026-10-09T20:46:04Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.publication_status

Source artifact SHA-256: 64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Retrieved at
2026-10-09T20:46:04Z
Source metadata		Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

Original source ↗

No field-specific location recorded

Version: 13059_2020_1954_MOESM9_ESM.xlsx
Retrieved: 2026-10-09T20:46:04Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.retrieved_at

Source artifact SHA-256: 64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Url
https://doi.org/10.1186/s13059-020-01954-z
Source metadata		Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

Original source ↗

No field-specific location recorded

Version: 13059_2020_1954_MOESM9_ESM.xlsx
Retrieved: 2026-10-09T20:46:04Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.url

Source artifact SHA-256: 64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Version
13059_2020_1954_MOESM9_ESM.xlsx
Source metadata		Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

Original source ↗

No field-specific location recorded

Version: 13059_2020_1954_MOESM9_ESM.xlsx
Retrieved: 2026-10-09T20:46:04Z

catalogued

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Supplementary workbook as served by the publisher.
Source metadata		Chen et al. 2020, Additional file 9: Performance metrics of 33 algorithms, median-score threshold, benchmark 2 (OncoKB)

Original source ↗

No field-specific location recorded

Version: 13059_2020_1954_MOESM9_ESM.xlsx
Retrieved: 2026-10-09T20:46:04Z

catalogued

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-02-a7f03c9e55a5 · Record review: source checked

Supplementary workbook as served by the publisher.

Release history

No supporting source is linked yet.

Read original source

Download this release (gzip)
Technical metadata and extraction receipts

Stable ID: somatic-oncogenicity-20261009-source-chen2020-additional-file-9

areas
dna-genomes
contexts
clinical_research
url
https://doi.org/10.1186/s13059-020-01954-z
artifact url
https://static-content.springer.com/esm/art%3A10.1186%2Fs13059-020-01954-z/MediaObjects/13059_2020_1954_MOESM9_ESM.xlsx
version
13059_2020_1954_MOESM9_ESM.xlsx
retrieved at
2026-10-09T20:46:04Z
artifact sha256
64b284aefb768c963a5e7079594d3bb7173ef3a5a5e6b0936d0a78126f25440c
doi
10.1186/s13059-020-01954-z
publication status
peer_reviewed
licence
CC-BY-4.0
media type
application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
Related records

    Suggest a correction